Artelo Biosciences Current Ratio vs. Total Debt
| ARTL Stock | USD 1.05 0.08 8.25% |
Current Ratio | First Reported 2010-12-31 | Previous Quarter 16.52 | Current Value 17.35 | Quarterly Volatility 6.75205444 |
For Artelo Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Artelo Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Artelo Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Artelo Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Artelo Biosciences over time as well as its relative position and ranking within its peers.
Artelo |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.87) | Return On Assets (0.54) | Return On Equity (0.89) |
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Artelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Artelo Biosciences Total Debt vs. Current Ratio Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Artelo Biosciences's current stock value. Our valuation model uses many indicators to compare Artelo Biosciences value to that of its competitors to determine the firm's financial worth. Artelo Biosciences is rated third in current ratio category among its peers. It is rated below average in total debt category among its peers making up about 30,535 of Total Debt per Current Ratio. At this time, Artelo Biosciences' Current Ratio is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Artelo Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Artelo Total Debt vs. Current Ratio
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Artelo Biosciences |
| = | 42.28 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Artelo Biosciences |
| = | 1.29 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Artelo Total Debt vs Competition
Artelo Biosciences is rated below average in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 165.82 Million. Artelo Biosciences maintains roughly 1.29 Million in total debt contributing less than 1% to equities under Health Care industry.
Artelo Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Artelo Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Artelo Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Artelo Biosciences' change in net profit over the period of time. It can combine multiple indicators of Artelo Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -228.6 K | -217.2 K | |
| Operating Income | -9.9 M | -9.4 M | |
| Net Loss | -9.3 M | -8.8 M | |
| Income Before Tax | -9.3 M | -8.8 M | |
| Total Other Income Expense Net | 641 K | 673 K | |
| Net Loss | -6.7 M | -6.4 M | |
| Net Loss | -9.3 M | -8.8 M | |
| Income Tax Expense | -188.1 K | -197.5 K | |
| Change To Netincome | 1.8 M | 1.9 M | |
| Net Loss | (4.01) | (4.21) | |
| Income Quality | 0.71 | 0.70 | |
| Net Income Per E B T | 0.88 | 0.78 |
Artelo Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Artelo Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Artelo Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Artelo Biosciences' important profitability drivers and their relationship over time.
Use Artelo Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Artelo Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will appreciate offsetting losses from the drop in the long position's value.Artelo Biosciences Pair Trading
Artelo Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Artelo Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Artelo Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Artelo Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Artelo Biosciences to buy it.
The correlation of Artelo Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Artelo Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Artelo Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Artelo Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Artelo Biosciences position
In addition to having Artelo Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Basic Utilities Thematic Idea Now
Basic Utilities
Companies involved in production and distribution of electric, gas, water, and other energy utilities. The Basic Utilities theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Basic Utilities Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
To fully project Artelo Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Artelo Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Artelo Biosciences' income statement, its balance sheet, and the statement of cash flows.